Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,000
Closed -$128K 703
2024
Q4
$128K Buy
+10,000
New +$2.97M 0.01% 366
2023
Q1
Sell
-11,500
Closed -$14K 1153
2022
Q4
$14K Buy
11,500
+1,300
+13% +$348K ﹤0.01% 1042
2022
Q3
$74K Sell
10,200
-2,000
-16% -$485K ﹤0.01% 870
2022
Q2
$64K Sell
12,200
-6,100
-33% -$1.49M ﹤0.01% 989
2022
Q1
$85K Sell
18,300
-3,200
-15% -$735K ﹤0.01% 1105
2021
Q4
$160K Buy
21,500
+5,100
+31% +$1.08M ﹤0.01% 1086
2021
Q3
$276K Sell
16,400
-1,000
-6% -$230K 0.01% 901
2021
Q2
$121K Buy
17,400
+4,800
+38% +$1.18M ﹤0.01% 1153
2021
Q1
$107K Sell
12,600
-500
-4% -$119K 0.01% 925
2020
Q4
$100K Sell
13,100
-1,800
-12% -$415K ﹤0.01% 1168
2020
Q3
$32K Buy
14,900
+3,400
+30% +$842K ﹤0.01% 1062
2020
Q2
$38K Sell
11,500
-3,300
-22% -$753K ﹤0.01% 1118
2020
Q1
$152K Sell
14,800
-5,200
-26% -$1.14M 0.01% 590
2019
Q4
$7K Buy
20,000
+8,100
+68% +$1.79M ﹤0.01% 1041
2019
Q3
$34K Buy
+11,900
New +$2.28M ﹤0.01% 813
2019
Q2
Sell
-22,300
Closed -$52K 1106
2019
Q1
$52K Buy
+22,300
New +$4.26M ﹤0.01% 663
2018
Q1
Sell
-12,400
Closed -$20K 922
2017
Q4
$20K Sell
12,400
-2,100
-14% -$372K ﹤0.01% 784
2017
Q3
$16K Sell
14,500
-7,600
-34% -$1.35M ﹤0.01% 770
2017
Q2
$60K Sell
22,100
-13,100
-37% -$2.13M ﹤0.01% 665
2017
Q1
$240K Buy
35,200
+19,300
+121% +$3.21M 0.01% 454
2016
Q4
$150K Sell
15,900
-300
-2% -$45.1K 0.01% 506
2016
Q3
$63K Buy
16,200
+2,700
+20% +$457K ﹤0.01% 663
2016
Q2
$77K Buy
+13,500
New +$2.1M ﹤0.01% 546
2016
Q1
Sell
-10,500
Closed -$23K 781
2015
Q4
$23K Sell
10,500
-3,400
-24% -$534K ﹤0.01% 719
2015
Q3
$70K Buy
+13,900
New +$2.19M ﹤0.01% 664
2014
Q3
Sell
-400,700
Closed -$87K 995
2014
Q2
$87K Buy
400,700
+351,200
+709% +$40.7M ﹤0.01% 668
2014
Q1
$57K Sell
49,500
-52,400
-51% -$6.36M ﹤0.01% 769
2013
Q4
$441K Buy
+101,900
New +$11.6M 0.01% 596

Other funds holding AMGN

HAP Trading's AMGN Position: Q1 2023 in Review

HAP Trading sold out of Amgen (AMGN) in Q1 2023, closing a stake of 29,148 shares — an estimated $7.16M sold.

HAP Trading first reported a position in AMGN in Q1 2014 and held it in 7 quarters. The position peaked at $7.66M in Q4 2022. 2,435 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • HAP Trading reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • HAP Trading sold 29,148 Amgen shares in Q1 2023, an estimated $7.16M.
  • HAP Trading first reported a position in Amgen in Q1 2014 and held it in 7 quarters.
  • HAP Trading's Amgen position peaked at $7.66M in Q4 2022.
  • 2,435 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.